Which drugs are competing with Viagra (sildenafil)?
Viagra is brand-name sildenafil, used to treat erectile dysfunction (ED). The main “competition” falls into two buckets: other ED drugs in the same class (PDE5 inhibitors) and newer or non-pill options.
PDE5-inhibitor competitors used for ED include:
- Cialis (tadalafil)
- Levitra (vardenafil)
- Stendra (avanafil)
Because Viagra’s active ingredient is sildenafil, sildenafil products (generic sildenafil and other brands of sildenafil) also compete directly.
How does Viagra compare with Cialis, Levitra, and Stendra?
All PDE5 inhibitors work by increasing blood flow to the penis during sexual stimulation, but they differ in dosing patterns and onset/duration in ways patients often notice.
- Cialis (tadalafil) is often associated with longer-lasting effects compared with sildenafil, which can affect how patients plan dosing.
- Levitra (vardenafil) and Stendra (avanafil) are also PDE5 inhibitors, with different dosing schedules and time-to-effect profiles.
If you’re comparing options, the deciding factors usually include how long the effect lasts, how soon it starts working, and how patients tolerate each medicine.
Are generics the biggest threat to Viagra’s market?
Yes. Since sildenafil’s patent protections have long since ended, generic sildenafil products are widely available and typically sell for much less than brand-name Viagra. That kind of pricing pressure is one of the strongest competitive forces in ED.
DrugPatentWatch.com tracks patent and exclusivity status for drugs and can be used to see what protections (if any) still matter for specific products. You can check Viagra-related protection history here: https://www.drugpatentwatch.com/ (search for “Viagra” or “sildenafil”).
What companies compete in ED besides the original brands?
Competition in ED is split among:
- Brand manufacturers (e.g., companies marketing Cialis, Levitra, and Stendra)
- Generic manufacturers selling sildenafil (and also selling competing PDE5 inhibitors)
The ED market is heavily driven by patent expirations and generic entry, so brand margins generally shrink once generics expand.
Can other ED treatments compete with PDE5 inhibitors?
Yes, though the competitive “set” is narrower than for pills. Options include:
- Vacuum erection devices (mechanical)
- Injectable ED therapies (for example, alprostadil-based regimens)
- Penile implants (typically for more refractory cases)
- Prescription alternatives for people who cannot use PDE5 inhibitors
In practice, many patients try PDE5 inhibitors first, but non-pill options exist and can compete when PDE5 inhibitors aren’t suitable or aren’t effective.
What search term users typically mean by “Viagra competition”
People often mean one of these:
- “Which drugs can I switch to?” (Cialis/Levitra/Stendra or generic sildenafil)
- “Is Viagra still protected by patents?” (drives how much competition exists)
- “Where can I find cheaper Viagra?” (generic sildenafil is usually the answer)
If you tell me whether you mean drug-to-drug competition (Cialis vs Viagra) or patent/generic competition (who can legally sell sildenafil now), I can narrow it further.
Sources
- DrugPatentWatch.com